Yes, an infection can raise blood sugar levels in non-diabetics, typically by 20 to 60 mg/dL during the acute illness, and occasionally higher. The mechanism is a stress-hormone surge: immune signals trigger cortisol, glucagon, and adrenaline, which push the liver to release glucose while making muscle and fat cells more resistant to insulin. In people without diabetes, peak glucose usually stays below 140 mg/dL fasting or 180 mg/dL after meals, and it normalizes within 3 to 10 days after fever resolves. Values above 180 mg/dL fasting, or readings that stay elevated more than two weeks after recovery, are not a normal infection response and warrant medical evaluation.

The mechanism: why infection pushes glucose up

An infection is a whole-body stress event, and the body responds the way it responds to any stressor: it floods the bloodstream with hormones that raise glucose. This is not a malfunction. It is an evolved defense that prioritizes fuel delivery to immune cells and the brain while the body fights an invader.

The sequence starts when immune cells recognize pathogen molecules. Within minutes to hours, they release cytokines, chiefly interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha). These cytokines travel to the brain and to the adrenal glands and act on three systems at once: the hypothalamic-pituitary-adrenal axis, the pancreatic alpha cells, and the sympathetic nervous system.

The HPA axis produces cortisol, which peaks at 2 to 3 times baseline during moderate infection and can rise 5 to 10 times baseline in severe sepsis. Cortisol does three things relevant to glucose. It tells the liver to increase gluconeogenesis, the manufacture of new glucose from amino acids and glycerol. It reduces glucose uptake in muscle. And it blunts insulin signaling, so the same amount of insulin clears less glucose than normal. Cortisol's effect builds slowly, over hours, and lingers long after the infection clears.

Glucagon rises in parallel. The cytokine IL-6 directly stimulates pancreatic alpha cells to release glucagon, which drives hepatic glycogenolysis, the breakdown of stored glycogen into glucose. In a well-nourished adult, the liver holds roughly 100 grams of glycogen, enough to release 400 kcal of glucose over the first 12 to 24 hours of illness. After that store depletes, gluconeogenesis carries the load.

Adrenaline, released in the early acute phase, adds a fast spike. It inhibits insulin release and stimulates glycogen breakdown, which is why a feverish chill or rigors can push glucose up sharply within 30 to 60 minutes.

The fourth leg is insulin resistance itself. Cytokines and cortisol together impair the insulin receptor's downstream signaling, so muscle and fat take up 30 to 50 percent less glucose for the same insulin concentration during a moderate infection. The pancreas compensates by secreting more insulin, and in most non-diabetics the compensation is adequate. When it is not, glucose climbs above normal.

In plain terms: an infection is a fire alarm that makes the liver dump sugar and makes the body's tissues ignore insulin, all so fuel reaches the cells fighting the infection.

Quantified context: how high does glucose actually go

The scale matters, because "raised" can mean a 15 mg/dL bump or a 150 mg/dL surge. In non-diabetics, most data come from hospital studies of patients without prior diabetes who develop acute infection or sepsis. The consistent finding is a rise proportional to infection severity.

For a mild upper respiratory infection or uncomplicated urinary tract infection, fasting glucose in a non-diabetic typically rises 10 to 30 mg/dL above their personal baseline. A person whose baseline fasting glucose is 88 mg/dL might sit at 105 to 120 mg/dL for two or three days. That range is still within normal fasting limits (below 100 mg/dL) or just into the prediabetic band, and it resolves.

For moderate infection with fever and systemic symptoms such as influenza or a significant bacterial infection, the rise is larger. Fasting glucose commonly reaches 110 to 140 mg/dL, and post-meal readings can reach 160 to 180 mg/dL. Roughly 25 to 40 percent of non-diabetic patients hospitalized with acute infection show at least one glucose reading above 140 mg/dL.

For severe infection or sepsis, glucose is often overtly elevated. In patients without known diabetes admitted with sepsis, 30 to 50 percent have at least one glucose above 180 mg/dL, and 10 to 20 percent exceed 250 mg/dL. This is called stress hyperglycemia, and it is associated with longer hospital stays and higher mortality even after adjusting for infection severity.

The counterintuitive part is the floor side. Severe infection can also cause low glucose, below 70 mg/dL, in up to 5 to 10 percent of critically ill non-diabetic patients, mostly from depleted glycogen stores, poor intake, and impaired gluconeogenesis in liver dysfunction. So the glucose response to infection is not a one-way ramp. It is a redistribution that can overshoot or undershoot.

Comparison table: how infection-related glucose rise differs by cause

Feature Mild infection (URI, UTI) Moderate infection (influenza, cellulitis) Severe infection (sepsis) Non-infectious stress (surgery, trauma)
Typical fasting peak 90 to 120 mg/dL 110 to 140 mg/dL 140 to 250 mg/dL or higher 120 to 180 mg/dL
Typical post-meal peak 130 to 150 mg/dL 150 to 180 mg/dL 180 to 300 mg/dL 160 to 200 mg/dL
Cortisol rise 1.5 to 2 times baseline 2 to 3 times baseline 5 to 10 times baseline 2 to 4 times baseline
Duration of elevation 1 to 3 days 3 to 7 days 7 to 14 days, sometimes longer 2 to 5 days
Risk of low glucose Very low Low 5 to 10 percent Low
Typical resolution Normalizes as fever ends Normalizes within a week May need insulin drip in hospital Normalizes with recovery

The key row is duration. Infection-related glucose elevation tracks the immune response, not the pathogen load, which is why it can persist a few days after fever breaks and typically resolves within two weeks.

The timeline: how long glucose stays elevated

Glucose does not rise and fall with the thermometer. It follows the cytokine and cortisol curve, which lags behind symptoms by 24 to 72 hours at both ends. The table below shows the typical course in a non-diabetic adult with moderate infection.

Time point What is happening Typical glucose change What it means
Hour 0 to 6 Pathogen recognized, adrenaline and early cytokines surge +10 to 25 mg/dL, fast Chills and rigors can spike glucose quickly
Hour 6 to 24 Cortisol and glucagon rise, liver glycogen mobilized +20 to 40 mg/dL Fasting reading may already be above baseline
Day 2 to 3 Fever peaks, insulin resistance peaks +30 to 60 mg/dL above baseline Highest readings usually occur here
Day 3 to 5 Fever breaks, cortisol begins falling +15 to 35 mg/dL Post-meal readings remain elevated a day after fever resolves
Day 5 to 7 Cytokines normalize, insulin sensitivity returns +5 to 15 mg/dL Fasting glucose approaching baseline
Day 7 to 10 Full recovery in most non-diabetics Back to baseline Glucose should be normal if measured fasting
Day 10 to 14 Residual cortisol effects gone Baseline Persistent elevation past this point is abnormal
Beyond 14 days — If still elevated, investigate Warrants a fasting glucose or A1c test

The practical takeaway: the highest glucose readings cluster on day 2 to 3 of illness, and a single high reading on day 1 does not predict a bad course. A reading taken 48 hours after fever has fully resolved is far more informative.

Who is at higher risk: non-diabetic edge cases

"Non-diabetic" is a wide category, and some people in it respond to infection much more strongly than others. These are the edge cases that matter.

Age is the clearest factor. Adults over 65 have higher baseline cortisol and blunted insulin secretion reserve, and studies of older non-diabetic adults hospitalized with pneumonia show glucose peaks 10 to 20 mg/dL higher than age-matched younger patients for the same infection severity.

Obesity and metabolic syndrome are the second factor. A person with a normal fasting glucose but central obesity often has insulin resistance at baseline, so the added infection-related resistance tips them over the threshold faster. Up to 30 percent of non-diabetic adults with obesity exceed 180 mg/dL during moderate infection, compared with under 10 percent of lean adults.

Pregnancy is a special case. Late pregnancy is a state of physiological insulin resistance, and infection can push glucose meaningfully higher. Gestational diabetes screening is often deferred during acute illness for this reason, because results are unreliable.

Medications matter more than most people realize. Corticosteroids such as prednisone raise glucose directly and add to infection-driven cortisol. A single 40 mg dose of prednisone can raise post-meal glucose by 30 to 50 mg/dL in a non-diabetic. Thiazide diuretics, some antipsychotics, and beta-blockers also shift glucose upward, so an infection during a steroid burst can produce genuinely surprising readings.

Finally, severe illness itself is a category. Sepsis, regardless of prior glucose status, produces stress hyperglycemia in a large fraction of patients. This is a distinct clinical entity, not a normal infection response, and it is managed in hospital with insulin protocols.

Corrected misconceptions

Several widespread beliefs about infection and blood sugar are wrong or incomplete.

The first misconception is that only diabetics see glucose rise during infection. In fact, every non-diabetic sees a rise, usually 20 to 60 mg/dL for moderate illness. The difference is that non-diabetics have the pancreatic reserve to keep the peak bounded, so the rise is smaller and shorter. The mechanism is identical; the magnitude differs.

The second misconception is that a single high reading during a fever means the person has undiagnosed diabetes. It does not. A fasting glucose of 130 mg/dL on day 2 of influenza is compatible with normal glucose metabolism, because the stress response alone can produce it. Diagnosis of diabetes requires a fasting glucose of 126 mg/dL or higher on two occasions, or an A1c of 6.5 percent or higher, per the American Diabetes Association, and testing during acute illness is discouraged for exactly this reason. Testing 4 to 6 weeks after recovery is the correct approach.

The third misconception is that sugar feeds the infection, so eating sugar makes infection worse. There is no good evidence in humans that modest dietary sugar during illness worsens infection outcomes in non-diabetics. The body is making its own glucose from stored glycogen and protein regardless of intake. Severe hyperglycemia does impair immune function, but that is a hospital-level concern, not a reason to avoid orange juice during a cold.

The fourth misconception is that glucose rises only with fever. Some infections, particularly those with strong cytokine responses but low fever, still raise glucose. Conversely, a high fever from a non-infectious cause such as heat stroke can also raise glucose. Fever and glucose are correlated but not identical.

What to actually do

For a non-diabetic who feels ill and wants to know whether glucose is a concern, the actions are simple and proportionate.

  • Do not diagnose diabetes from a sick-day reading. If you happen to check glucose during an infection, treat values up to 180 mg/dL as expected and recheck fasting 4 to 6 weeks after full recovery.
  • Stay hydrated and eat normally if you can tolerate food. Illness-related glucose rise is not driven by eating, and under-eating during infection can worsen the risk of low glucose.
  • Avoid adding steroid medication unless a clinician prescribed it for the infection. Over-the-counter steroid creams are fine; oral steroid bursts during infection are a common and avoidable cause of large glucose spikes.
  • Check glucose if you have symptoms that do not fit the infection, such as excessive thirst, frequent urination, or unusual fatigue that persists after fever resolves.
  • If you are over 65, pregnant, or have obesity, be more attentive to prolonged fatigue or thirst after an infection and mention it at a follow-up visit.

Red flags that need medical attention

Most infection-related glucose elevation is benign and self-limited. These signs are not.

  • Fasting glucose above 180 mg/dL, or any reading above 250 mg/dL, especially with vomiting or difficulty keeping fluids down.
  • Glucose that stays elevated more than two weeks after fever and other symptoms have fully resolved.
  • Symptoms of high glucose during or after infection: intense thirst, urinating much more than usual, blurred vision, or unexplained weight loss.
  • Symptoms of low glucose, particularly in severe illness: shakiness, confusion, sweating, or fainting, which can occur when glycogen stores are depleted.
  • A known non-diabetic who develops repeated infections alongside rising glucose, which can occasionally be the first sign of an underlying condition such as hemochromatosis or pancreatic disease.

Limitations and what the evidence cannot say

The evidence base here is uneven. Most quantitative data on infection-related glucose rise come from hospitalized patients, often with severe infection, so the exact numbers for a mild cold in an otherwise healthy adult are extrapolated rather than directly measured. Continuous glucose monitoring studies in non-diabetics during mild infection are scarce, and the 20 to 60 mg/dL range for moderate illness is a reasonable synthesis rather than a single trial result.

The boundary between normal stress hyperglycemia and pathological hyperglycemia in non-diabetics is also not sharply defined. The 140 mg/dL and 180 mg/dL thresholds come largely from critically ill and diabetic populations, and their meaning in a mildly ill non-diabetic is less certain. A fasting glucose of 126 mg/dL or higher on two occasions, or an A1c of 6.5 percent or higher, remains the diagnostic standard per the American Diabetes Association, but those criteria were not designed for sick-day testing.

Finally, the long-term significance of a single episode of infection-related hyperglycemia in a non-diabetic is an open question. Some studies suggest that people who mount large glucose responses to infection have a higher future risk of type 2 diabetes, but whether the infection response is causal or simply reveals pre-existing beta-cell vulnerability is unresolved. The honest answer is that the mechanism is well established, the short-term numbers are reasonably characterized, and the long-term implications remain a hypothesis rather than a settled finding.